Al's Comment:

 We helped fund this project  (through the DIPG Collaborative).  It shows that a liquid biopsy of CSF or even Blood can tell if the patient is responding or not to Onc-201.  With DIPG it is hard to tell how the tumor is doing with just MRIs.  It also shows impressive results for Onc-201!

---

Posted on: 08/16/2022

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma 

 

---

Click HERE to return to brain tumor news headlines.